Plasma thromboxane and prostacyclin are linearly related and increased in patients presenting with acute myocardial infarction

Gurbel, 1998, For the GUSTO III Investigators. Effects of reteplase and alteplase on platelet aggregation and major receptor expression during the first 24 hours of acute myocardial infarction treatment. The GUSTO III Platelet Study, J Am Coll Cardiol, 31, 1466, 10.1016/S0735-1097(98)00172-7 Selwyn, 1997, Cell dysfunction in atherosclerosis and the ischemic manifestations of coronary artery disease, Am J Cardiol, 79, 17, 10.1016/S0002-9149(97)00125-2 Frandsen, 1996, Time course of platelet α granule release in acute myocardial infarction treated with streptokinase, Heart, 75, 141, 10.1136/hrt.75.2.141 Langford, 1996, Platelet activation in acute myocardial infarction and unstable angina is inhibited by nitric oxide donors, Arterioscl Thromb Vasc Biol, 16, 51, 10.1161/01.ATV.16.1.51 Willerson, 1995, Conversion from chronic to acute coronary heart disease syndromes. Role of platelets and platelet products, Texas Heart Inst J, 22, 13 Opie, 1995, New concepts regarding events that lead to myocardial infarction, Cardiovasc Drugs Therap, 9, 479, 10.1007/BF00877858 Saldeen, 1993, Increased production of thromboxane A2 by coronary arteries after thrombolysis, Am Heart J, 125, 277, 10.1016/0002-8703(93)90001-P Tosaki, 1991, Effect of cicletanine on reperfusion induced arrhythmias and its relation to 6-keto PGF1 alpha and thromboxane B2 release, Canad J Physiol Pharm, 69, 488, 10.1139/y91-073 Corsi, 1993, Possible role of defibrotide in endothelial cell protection, Int J Tiss React, 15, 157 Serebruany, 1997, Serial changes of the plasma prostanoids during myocardial ischemia – reperfusion in swine: Effectsof magnesium, diltiazem, and a novel Mac-1 inhibitor, Prostaglandins Leukot Essent Fatty Acids, 56, 135, 10.1016/S0952-3278(97)90510-X Singh, 1997, Protective actions of a thromboxane receptor antagonist SQ 29548 in the ischemic myocardium: morphologic and hemodynamic effects, Prostaglandins Leukot Essent Fatty Acids, 56, 105, 10.1016/S0952-3278(97)90505-6 Fitzgerald, 1988, Marked platelet activation in vivo after intravenous streptokinase in patients with acute myocardial infarction, Circulation, 77, 142, 10.1161/01.CIR.77.1.142 Takase, 1996, Arachidonic acid metabolites in acute myocardial infarction, Angiology, 47, 649, 10.1177/000331979604700703 Hohlfeld, 1993, Stimulation of endogenous prostacycline protects the reperfused pig myocardium from ischemic injury, J Pharm Exper Therap, 264, 397 Riva, 1990, Iloprost inhibits neutrophil-induced lung injury and neutrophil adherence to endothelial monolayers, Amer J Resp Cell & Molec Biol, 3, 301, 10.1165/ajrcmb/3.4.301 Ueno, 1994, Beraprost sodium protects occlusion/reperfusion injury in the dog by inhibition of neutrophil migration, Gen Pharm, 25, 427, 10.1016/0306-3623(94)90192-9 Sato, 1993, Effects of thromboxane synthetase inhibitor, Y-20811, on infarct size, neutrophil accumulation, and arrhythmias after coronary artery occlusion and reperfusion in dogs, J Cardiovasc Pharm, 21, 353, 10.1097/00005344-199303000-00002 Kanayama, 1993, A new prostacyclin analog, KP-10614, inhibits platelet-polymorphonuclear leukocyte interaction and limits experimental infarct size in rat heart, J Pharm Exp Therap, 266, 344 Okuyama, 1995, PGI2 analogue, sodium beraprost, suppresses superoxide generation in human neutrophils by inhibiting p47phox phosphorylation, Life Sci, 57, 1051, 10.1016/0024-3205(95)02050-S Savage, 1995, Effect of thromboxane A2 blockade on clinical outcome and restenosis after successful coronary angioplasty. Multi-Hospital Eastern Atlantic Restenosis Trial (M-HEART-II), Circulation, 92, 3194, 10.1161/01.CIR.92.11.3194 Kernis, 1992, Pharmacokinetics of tissue – type plasminogen activator during acute myocardial infarction in men. Effect of prostacyclin analogue, Circulation, 85, 526, 10.1161/01.CIR.85.2.526 Theroux, 1990, Hemodynamic, platelet and clinical responses to prostacyclin in unstable angina pectoris, Am J Cardiol, 65, 1084, 10.1016/0002-9149(90)90318-U 1994, Circulation, 89, 588, 10.1161/01.CIR.89.2.588 Rasmanis, 1988, Effect of intermittent treatment with aspirin on thromboxane and prostacyclin formation in patients with acute myocardial infarction, Lancet, 8605, 245, 10.1016/S0140-6736(88)92537-8 Rasmanis, 1995, Implications of the prognostic importance of exercise-induced thromboxane formation in survivors of an acute myocardial infarction, Prostaglandins, 49, 247, 10.1016/0090-6980(95)00019-7 Rasmanis, 1991, Prostacyclin production in myocardial infarction in the acute phase and during follow-up, J Intern Med, 229, 135, 10.1111/j.1365-2796.1991.tb00321.x Fitzgerald, 1986, Platelet activation in unstable coronary disease, New Engl J Med, 315, 983, 10.1056/NEJM198610163151602 Jaschonek, 1986, Platelet prostacyclin binding in coronary artery disease, J Am Coll Cardiol, 8, 259, 10.1016/S0735-1097(86)80037-7 Mueller, 1986, Platelet hyperactivity in acute myocardial infarction in man – effect of prostacyclin, Herz, 11, 116 Serebruany, 1998, Depressed platelet status in a patient with hemorrhagic stroke following thrombolysis for acute myocardial infarction, Stroke, 29, 235, 10.1161/01.STR.29.1.235 Serebruany, 1998, Heterogeneity of platelet aggregation and major surface receptor expression in patients presenting with acute myocardial infarction, Am Heart J, 136, 398, 10.1016/S0002-8703(98)70212-1 Prentice, 1993, Antithrombotic therapy in the secondary prevention of myocardial infarction, Am J Cardiol, 72, 175G, 10.1016/0002-9149(93)90125-V 1990, Lancet, 336, 827, 10.1016/0140-6736(90)92336-G Serebruany, 1998, Antecedent aspirin therapy inhibits baseline platelet status in patients presenting with acute myocardial infarction, Cardiology, 90, 37, 10.1159/000006814